Instylla Announces the Appointment of Daniel Davis to Board of Directors [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
embolization, has announced the appointment of Daniel Davis to its Board of Directors. Mr. Davis is Chief Strategy Officer at Imperative Care, where he has led growth, development, and strategic initiatives for its stroke and vascular technologies. Daniel has over 25 years of experience in sales, marketing, and business development with early-stage and Fortune 500 medical device companies. Before joining Imperative Care in 2020, Mr. Davis served as Chief Commercial Officer and President of North America at Penumbra, Inc., where he led the commercialization of embolization and mechanical thrombectomy technologies for neurovascular and peripheral vascular applications. "We are very pleased to welcome Daniel Davis to the Board at Instylla. Daniel's incisive leadership and deep industry experience will be a strong match for our Board as we drive commercialization for our next generation liquid embolics," said Amar Sawhney , Chairman and CEO of Instylla, Inc. and Managing Director of I
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra (NYSE:PEN) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.MarketBeat
- Penumbra (NYSE:PEN) was given a new $345.00 price target on by analysts at Robert W. Baird.MarketBeat
- Penumbra (NYSE:PEN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
- Penumbra (NYSE:PEN) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Penumbra (NYSE:PEN) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
PEN
Earnings
- 11/5/25 - Beat
PEN
Sec Filings
- 12/15/25 - Form 4
- 12/9/25 - Form 4
- 12/3/25 - Form 4
- PEN's page on the SEC website